GPX4 and cholangiocarcinoma: Although evidence directly connecting ERO1α to ferroptosis remains limited, Wang et al. [57] demonstrated that in cholangiocarcinoma (CCA) cells, 2′,4′-dihydroxychalcone (2′,4′-DHC) targets ERO1α, inducing GPX4 degradation and ferroptosis.